DealsMay 12, 2026, 02:36 PM
BioHarvest Secures Stage 2 Contract for Rare Fragrance Plant
AI Summary
BioHarvest Sciences Inc. announced it has secured a Stage 2 contract for the development of a rare scent-producing plant used in the global fragrance industry. This contract follows the successful completion of Stage 1 and aims to produce enough raw material for commercial trials within six to nine months. Under the terms, BioHarvest retains 20% ownership of the developed compositions and will earn a second revenue stream as the manufacturing entity, establishing a long-term, royalty-driven economic model. The company anticipates being ready for production in the second half of 2027, targeting the growing premium fragrance market.
Key Highlights
- BioHarvest secured a Stage 2 contract for a rare scent-producing plant development.
- BioHarvest retains 20% ownership of successfully developed compositions.
- Company will earn a second revenue stream as the manufacturing entity.
- The agreement establishes a long-term, royalty-driven economic model.
- Stage 2 completion in 6-9 months will produce material for commercial trials.
- Production is expected to begin in the second half of 2027.
- Targets the $23 billion premium fragrance segment of the $58.9 billion industry.
- Partner is a prominent United Arab Emirates-based investment group.
Price Impact
More from BHST